Darunavir structure
Darunavir
Darunavir(TMC114) is an HIV protease inhibitor.IC50 Value: Target: HIV ProteaseDarunavir HIV-1 antiviral structurally is similar to amprenavir and it is second generation HIV-1-protease inhibitor. Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naive and treatment-experienced adults and adolescents.
Find 7 Related Holders
INNOVARE LABS PRIVATE LTD
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
LAURUS LABS LTD
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
RAKS PHARMA PVT LTD
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
MATRIX PHARMACORP PRIVATE LTD
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
ZYDUS LIFESCIENCES LTD
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
CIPLA LTD.
Brazil
Brazil
API Registration Country
API Active
-
Country:
Brazil -
Address:
VIKHROLI, EXTERIOR - EX
ZHEJIANG JIUZHOU PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Inactive
Recommended Suppliers of Darunavir
-
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier -
Shandong Airuike Chemical Co., Ltd.
CN1 YR
Contact Supplier -
BOC Sciences
US1 YR
Contact Supplier -
Amitychem
CN1 YR
Contact Supplier -
Hangzhou Raisun Import & Export Co Ltd
CN1 YR
Contact Supplier